K. Yagi

Follow-up study of children with nephrotic syndrome treated with a long-term moderate dose of cyclosporine.

K. Yoshioka, S. Hino, T. Takemura, 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Expression of Fas antigen and Bcl-2 in human glomerulonephritis.

K. Yoshioka, T. Takemura, K. Murakami, 1995, Kidney international.

Promotion of survival and prevention of apoptosis in rat mesangial cells by a membrane-anchored form of heparin-binding EGF-like growth factor

K. Yoshioka, S. Hino, T. Takemura, 2001, Clinical and Experimental Nephrology.

In situ expression of cytokines in IgA nephritis.

K. Matsushima, K. Yoshioka, T. Takemura, 1993, Kidney international.

IgA nephropathy in patients with congenital C9 deficiency.

H. Akita, Y. Koitabashi, K. Yoshioka, 1992, Kidney international.

PROTO‐ONCOGENE EXPRESSION IN HUMAN GLOMERULAR DISEASES

K. Yoshioka, S. Hino, M. Okada, 1996, The Journal of pathology.

Association of INVS (NPHP2) mutation in an adolescent exhibiting nephronophthisis (NPH) and complete situs inversus.

M. Okada, K. Yagi, T. Takemura, 2008, Clinical nephrology.

Alport syndrome and benign familial hematuria (thin basement membrane disease) in two brothers of a family with hematuria.

K. Moriwaki, M. Okada, K. Yagi, 2003, Clinical nephrology.

Combined therapy in children and adolescents with IgA nephropathy.

K. Yoshioka, S. Hino, T. Takemura, 1994, Nihon Jinzo Gakkai shi.

Chronic renal insufficiency in a boy with cystic renal lymphangiectasia: morphological findings and long-term follow-up.

M. Okada, K. Yagi, T. Takemura, 2007, Clinical Nephrology.